Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/2014
08/12/2014US8802649 Methods and compositions for inhibiting the proliferation of cancer cells
08/12/2014US8802647 Materials and methods for prevention and treatment of RNA viral diseases
08/12/2014US8802643 Method for the treatment of malignancies
08/12/2014US8802642 Spinal muscular atrophy treatment via targeting SMN2 catalytic core
08/12/2014US8802641 Method for inhibiting onset of or treating pollen allergy
08/12/2014US8802639 RNA interference modulators of hedgehog signaling and uses thereof
08/12/2014US8802419 Modified pathogens for use as vaccines
08/12/2014US8802084 ACE2 activation for treatment of heart, lung and kidney disease and hypertension
08/12/2014CA2556435C Anti-microrna oligonucleotide molecules
08/12/2014CA2528053C Phl p 5a derivatives having reduced allergenicity and retained t-cell reactivity
08/12/2014CA2509666C Methods and compositions using compounds from fetal cells and tissues to improve condition of skin
08/12/2014CA2501422C Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease
08/07/2014WO2014121287A2 Selective antisense compounds and uses thereof
08/07/2014WO2014121256A1 Aptamers for tumor initiating cells
08/07/2014WO2014121050A1 Functionalized dna dendrimers for gene delivery to cells
08/07/2014WO2014120900A1 Enhanced therapeutic regimens for treating fabry disease
08/07/2014WO2014119823A1 Pharmaceutical composition for reducing or inhibiting scar formation, containing bmp-7 and diluting agent
08/07/2014WO2014118643A2 Methods of inducing responsiveness to anti-angiogenic agent
08/07/2014WO2014118346A1 Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failure
08/07/2014US20140221861 Contribution of oxidative stress to af electrograms
08/07/2014US20140221465 Modified polynucleotides for treating galactosylceramidase protein deficiency
08/07/2014US20140221455 Differentiation modulating agents and uses therefor
08/07/2014US20140220678 Methods and compositions relating to improved lentiviral vectors and their applications
08/07/2014US20140220676 Method and Medicament for Inhibiting the Expression of a Given Gene
08/07/2014US20140220600 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
08/07/2014US20140220113 Method and Medicament for Inhibiting the Expression of a Given Gene
08/07/2014US20140220060 Hiv-1 south african subtype c env proteins
08/06/2014EP2761010A1 LENTIVIRAL VECTORS PSEUDOTYPED WITH MUTANT BaEV GLYCOPROTEINS
08/06/2014EP2761009A1 Inducible adeno -associated virus vector mediated transgene ablation system
08/06/2014EP2760478A1 Apc-mediated tolerance induction for therapy of multiple sclerosis
08/06/2014EP2760437A1 Spray system for production of a matrix formed in situ
08/06/2014CN103974724A 修饰的核苷、核苷酸和核酸及其用途 Modified nucleosides, nucleotides and nucleic acids and their uses
08/06/2014CN103974716A 凝血因子Ⅶ和Ⅶa衍生物、包括其的缀合物和复合体及其用途 Coagulation factor Ⅶ and Ⅶa derivatives, including its conjugates and complexes and their uses
08/06/2014CN103966334A Csf2rb基因在前列腺癌骨转移中的应用 Csf2rb genes in prostate cancer bone metastasis
08/06/2014CN103966327A 一种miR-27a的应用及其诊断试剂盒 One kind of miR-27a Application and diagnostic kits
08/06/2014CN103966309A 外周血细胞TRPC6mRNA水平用于早期预测/诊断老年性痴呆 Peripheral blood cells TRPC6mRNA level for early prediction / diagnosis of senile dementia
08/06/2014CN103966260A 一种基于J亚群禽白血病病毒pol基因保守序列的siRNA重组干扰载体及其制备方法和应用 Based subgroup J avian leukemia virus pol gene conserved sequence of siRNA interference carrier recombination and its preparation method and application
08/06/2014CN103966259A 一种基于J亚群禽白血病病毒gag基因保守序列的siRNA重组干扰载体及其制备方法和应用 Based subgroup J avian leukemia virus gag gene conserved sequence of siRNA interference carrier recombination and its preparation method and application
08/06/2014CN103966238A 一种用于弓形虫感染预防的疫苗和制备方法及其应用 A method for the prevention of toxoplasmosis vaccine and preparation method and its application
08/06/2014CN103966237A 日本血吸虫Wnt5基因、蛋白及应用 Schistosoma Wnt5 gene, protein and application
08/06/2014CN103966227A 密码子优化的mg53蛋白的编码核苷酸序列、其重组体及其应用 Codon optimized nucleotide sequence encoding mg53 protein, which recombinant Its Applications
08/06/2014CN103966219A 人泡沫病毒载体介导的抑制HIV-1复制的shRNA的构建及应用 Construction and application of human foamy virus vector-mediated inhibition of HIV-1 replication of the shRNA
08/06/2014CN103966214A A型流感病毒PB基因有干扰作用的siRNA序列的设计及应用 PB influenza A virus gene interference design and application of siRNA sequences
08/06/2014CN103966213A A型流感病毒M基因有干扰作用的siRNA序列的设计和干扰作用的鉴定 Interference design and identification of influenza A virus M gene interference effect of siRNA sequences
08/06/2014CN103966212A A型流感病毒NP基因有干扰作用的siRNA序列的设计及应用 Type A influenza virus NP gene interference design and application of siRNA sequences
08/06/2014CN103965363A 与pd-1和vegf高效结合的融合蛋白、其编码序列及用途 And pd-1 and vegf efficient binding of the fusion protein coding sequence and use
08/06/2014CN103965362A 一种可使t细胞趋向肿瘤部位的嵌合趋化因子受体 T a system whereby tumor cells tend chimeric chemokine receptor
08/06/2014CN103965361A 一种t细胞信号的嵌合分子转换器及其用途 One kind of t cell signaling converter chimeric molecules and their uses
08/06/2014CN103965356A 针对VEGFR2的全人源抗体重链和轻链可变区及相应Fab和全长抗体 For fully human antibody heavy and light chain variable region and the corresponding VEGFR2 antibody Fab and full length
08/06/2014CN103965355A 针对VEGFR2的全人源抗体重链和轻链可变区及相应Fab和全长抗体 For fully human antibody heavy and light chain variable region and the corresponding VEGFR2 antibody Fab and full length
08/06/2014CN103961721A 减毒鼠伤寒沙门氏菌及其基因工程菌在制备治疗前列腺癌的药物上的应用 Attenuated Salmonella typhimurium and its genetically engineered bacteria used in the preparation of drugs for the treatment of prostate cancer
08/06/2014CN103961720A MicroRNA用于制备降低神经胶质瘤对TRAIL耐受性的药物的用途 MicroRNA for preparing reduced glioma TRAIL tolerance of a medicament for
08/06/2014CN103961719A microRNA-23b及其拟似物在制备防治肥胖、高血脂、高血压及其并发症的药物中的应用 microRNA-23b and its analogues in preparation prevention of obesity, high cholesterol, hypertension and its complications drug application
08/06/2014CN103961718A 一种免疫避孕核酸疫苗及其制备方法 An immune contraception DNA vaccine and its preparation method
08/06/2014CN103961706A 微小rna或其抑制剂在脂代谢调控中的应用 Small rna or inhibitors in the regulation of lipid metabolism
08/06/2014CN102973953B miRNA-874及其反义核苷酸的用途 miRNA-874 and its use of antisense oligonucleotide
08/06/2014CN102827840B 抑制PPFIA1基因表达的siRNA及其应用 Expression of siRNA gene inhibition PPFIA1 Its Applications
08/06/2014CN102747092B 表达o型口蹄疫病毒空衣壳的重组缺损腺病毒及其应用 O-expressing FMDV empty capsids recombinant adenovirus and its application defects
08/06/2014CN102327622B 一种利用介孔二氧化硅纳米颗粒装载siRNA的方法 A use of mesoporous silica nanoparticles loaded siRNA method
08/06/2014CN102174478B 一种光敏剂结合蛋白/多肽及其在光动力基因治疗中的应用 One kind of photosensitizer binding protein / peptide gene and its application in photodynamic therapy
08/06/2014CN102036689B 神经肌肉突触维持和再生中涉及的微小rna的鉴定 Neuromuscular synapse maintenance and regeneration micro rna involved identification
08/06/2014CN101415817B 截留干细胞及其使用 Retention of stem cells and their use
08/05/2014US8796444 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
08/05/2014US8796240 Cell growth inhibitor and screening method thereof
08/05/2014US8796236 Gene therapy for lysosomal storage diseases
08/05/2014US8796016 RNA interference mediating small RNA molecules
08/05/2014US8795734 Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
08/05/2014US8795666 Antagonists of IL-23P19 for treatement of atopic dermatitis
08/05/2014CA2736972C Tumour-associated peptides that bind to mhc molecules
08/05/2014CA2607150C Glucagon-like-peptide-2 (glp-2) analogues
08/05/2014CA2557737C Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications
08/05/2014CA2555390C Immunostimulatory viral rna oligonucleotides
08/05/2014CA2553886C Combined use of prame inhibitors and hdac inhibitors
08/05/2014CA2528597C Stabilized immunomodulatory oligonucleotides
08/05/2014CA2521839C Augmented cognitive training
08/05/2014CA2507115C Treatment of mammalian reaction to ige interactions
08/05/2014CA2466431C Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
08/05/2014CA2457140C Beta-amyloid-analogue - t-cell epitope vaccine
07/2014
07/31/2014WO2014117164A2 Airway device with tongue-engaging member
07/31/2014WO2014117089A1 Compositions and methods for the treatment of pervasive development disorders
07/31/2014WO2014116982A2 Methods of modulating gabaergic inhibitory synapse formation and function
07/31/2014WO2014116958A1 Compositions and methods involving endogenous retrovirus proteins
07/31/2014WO2014116937A1 Kv1.3 antagonists and methods of use
07/31/2014WO2014116652A2 Method and composition for treating spasticity
07/31/2014WO2014115158A1 METHOD FOR INHIBITING TUMOR GROWTH THROUGH RNA-INTERFERENCE USING LIPOSOMALLY ASSOCIATED CDC20 siRNA
07/31/2014WO2014093894A3 Dna antibody constructs and method of using same
07/31/2014WO2006015127A9 Treating cardiovascular tissue
07/31/2014US20140213635 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
07/31/2014US20140212969 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
07/31/2014US20140212946 Non-natural ribonuclease conjugates as cytotoxic agents
07/31/2014US20140212393 Compositions and Methods for the Treatment of Lysosomal Storage Disorders
07/30/2014EP2758082A2 Methods of treating fatty liver disease with helminth-derived glycan-containing compounds
07/30/2014EP2758069A2 Method to predict the presence of inflammation or itaconic acid, irg1 and/or protein irg1 in a subject and pharmaceutical composition for treating or preventing inflammation
07/30/2014EP2758036A2 Nano delivery systems
07/30/2014CN103958680A 缺血性疾病治疗药 Ischemic disease treatment drug
07/30/2014CN103958679A 变异型α-辅肌动蛋白-4的抗体 Variant α- actinin-4 antibody
07/30/2014CN103957944A 用含蠕虫衍生的聚糖的化合物治疗脂肪肝病的方法 Compounds containing a worm-derived glycans treatment of fatty liver
07/30/2014CN103957942A 方法 Method
07/30/2014CN103957935A 抗cgrp或抗cgrp-r抗体或抗体片段用于治疗或预防慢性和急性形式的腹泻的用途 Or anti-anti cgrp use cgrp-r antibody or antibody fragment for the treatment or prevention of diarrhea, chronic and acute forms of
07/30/2014CN103957925A 具有γ干扰素的抗原呈递癌症疫苗 IFN-γ has an antigen-presenting cancer vaccine
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 870